알피바이오
314140KOSDAQ· 의료용 물질 및 의약품 제조업6,000원+40 (+0.67%)시간외
52주 위치
4,8109,13028%신고가 대비 -34.28%
- 시가총액
- 520억
- PER
- 7.72
- PBR
- 0.45
- EPS(TTM)
- 777원
- BPS
- 13,472원
- 배당수익률
- 0.83%
- 자사주비율
- 0.19%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2022(별도) | 2023(별도) | 2024(별도) | 2025(별도) |
|---|---|---|---|---|
| ROE | 4.74% | 5.61% | -0.88% | 4.47% |
| ROA | 2.49% | 3.20% | -0.56% | 2.97% |
| 영업이익률 | 6.98% | 4.38% | -0.56% | 3.73% |
| 순이익률 | 3.12% | 3.60% | -0.73% | 3.44% |
| 매출총이익률 | 12.87% | 10.31% | 5.81% | 10.16% |
| 부채비율 | 90.00% | 61.77% | 55.91% | 45.76% |
| 유동비율 | 103.07% | 117.77% | 119.42% | 129.67% |
| 매출 성장률(YoY) | — | 9.37% | -17.93% | 9.88% |
| 영업이익 성장률(YoY) | — | -31.35% | -110.47% | — |
| 순이익 성장률(YoY) | — | 25.99% | -116.68% | — |
| FCF | -39.92억 | -5.43억 | 76.7억 | 72.76억 |
| FCF 마진 | -2.89% | -0.36% | 6.19% | 5.34% |
| CAPEX/매출 | 3.73% | 7.36% | 4.72% | 3.82% |
| 항목 | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q(별도) | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q(별도) | 2026 1Q(별도) | 2026 2Q(별도) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.80% | -3.72% | 0.56% | 2.09% | 3.31% | -0.48% | -0.52% | 0.12% | -1.54% | 1.04% | 1.65% | 1.79% | 0.27% | 0.82% | 2.46% | 2.68% |
| ROA | 0.97% | -1.96% | 0.32% | 1.21% | 1.87% | -0.27% | -0.31% | 0.07% | -0.95% | 0.66% | 1.04% | 1.16% | 0.18% | 0.55% | 1.60% | 1.81% |
| 영업이익률 | 5.94% | 2.22% | 1.44% | 7.32% | 8.81% | -1.01% | -0.81% | 1.51% | -4.53% | 1.14% | 5.31% | 6.51% | 0.82% | 2.05% | 6.90% | 10.29% |
| 순이익률 | 4.59% | -10.04% | 1.55% | 5.46% | 7.84% | -1.31% | -1.59% | 0.37% | -5.61% | 3.42% | 4.99% | 5.17% | 0.83% | 2.59% | 7.45% | 7.47% |
| 매출총이익률 | 11.73% | 8.97% | 7.34% | 13.65% | 13.46% | 5.97% | 5.41% | 7.69% | 2.15% | 7.56% | 11.32% | 12.59% | 7.41% | 9.11% | 12.47% | 16.54% |
| 부채비율 | 85.27% | 90.00% | 74.74% | 73.05% | 69.55% | 61.77% | 60.33% | 57.24% | 54.78% | 55.91% | 57.64% | 50.24% | 46.41% | 45.76% | 50.64% | 46.04% |
| 유동비율 | 108.47% | 103.07% | 114.10% | 115.47% | 120.45% | 117.77% | 119.73% | 120.01% | 117.58% | 119.42% | 122.48% | 134.19% | 136.13% | 129.67% | 133.66% | 141.60% |
| 매출 성장률(YoY) | — | — | — | — | 14.41% | 5.32% | -8.50% | -16.64% | -32.27% | -12.01% | 4.63% | 11.29% | 18.21% | 6.43% | 3.34% | 11.40% |
| 영업이익 성장률(YoY) | — | — | — | — | 69.79% | -147.90% | -151.35% | -82.80% | -134.83% | — | — | 379.88% | — | 91.40% | 34.27% | 76.00% |
| 순이익 성장률(YoY) | — | — | — | — | 95.11% | — | -194.17% | -94.32% | -148.54% | — | — | 1448.41% | — | -19.32% | 54.27% | 60.80% |
| FCF | — | -37.32억 | -32.84억 | -19.72억 | 30억 | 17.13억 | 12.15억 | 40.39억 | -10.55억 | 34.71억 | 27.21억 | 21.16억 | 9.63억 | 14.76억 | 80.9억 | -24.87억 |
| FCF 마진 | — | -11.05% | -9.25% | -5.13% | 7.23% | 4.82% | 3.74% | 12.59% | -3.75% | 11.09% | 8.00% | 5.93% | 2.90% | 4.43% | 23.03% | -6.25% |
| CAPEX/매출 | — | 5.57% | 4.57% | 7.98% | 8.30% | 8.40% | 1.57% | 5.79% | 10.65% | 1.58% | 4.94% | 0.87% | 7.82% | 1.84% | 0.84% | 0.92% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 00:17· 별도 · 산식은 항목 툴팁